I know I am becoming ancient but trial BIT225-012 offered tests on viral blood levels.
So far all we get is respiratory levels show no benefits.
How does that figure?
On BIT225-010 there is no word on whether there is any ongoing or permanent benefit achieved beyond the 16 week reporting period. Have any checks been made off possible changes to the deep HIV viral load that cART protects against full AIDs developing?
More questions than answers.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $210 | 104.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 38848316 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 18281126 | 25 |
View Market Depth
| Last trade - 12.28pm 27/06/2025 (20 minute delay) ? |
| BIT (ASX) Chart |